Jing Pan

Title: Jing Pan - Innovator in Pharmaceutical Chemistry

Introduction

Jing Pan is a notable inventor based in Xinchang County, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of methods for synthesizing important pharmaceutical compounds. His innovative approach has led to advancements in the production of sitagliptin, a medication used to treat type 2 diabetes.

Latest Patents

Jing Pan holds a patent for a method for preparing a sitagliptin intermediate. The patent describes a process that involves dissolving a specific compound into an organic solvent and utilizing fatty acid catalysis along with chlorosilane to perform a reduction reaction of carbon-carbon double bonds. This method is advantageous as it avoids the use of precious metals as catalysts, resulting in lower costs and simpler post-treatment processes. The product achieved through this method boasts a high yield, chemical purity, and optical purity, with a de % greater than 99.6%. This preparation method is not only efficient but also suitable for industrial production.

Career Highlights

Throughout his career, Jing Pan has worked with prominent organizations in the pharmaceutical industry. He has been associated with the Shanghai Institute of Pharmaceutical Industry and Zhejiang Medicine Co., Ltd. His work in these institutions has allowed him to refine his skills and contribute to significant advancements in pharmaceutical research and development.

Collaborations

Jing Pan has collaborated with several professionals in his field, including Kuaile Lin and Zhengyan Cai. These collaborations have fostered a productive environment for innovation and have led to the successful development of new methodologies in pharmaceutical synthesis.

Conclusion

Jing Pan's contributions to pharmaceutical chemistry, particularly through his patented method for synthesizing sitagliptin intermediates, highlight his role as an innovator in the field. His work not only enhances the efficiency of pharmaceutical production but also demonstrates the potential for cost-effective solutions in drug manufacturing.